Skip to main content
SpringerLink
Log in

Surgical Treatment for Basal Cell Carcinoma of the Head and Neck

  • Chapter
  • First Online:
Basal Cell Carcinoma

  • 1059 Accesses

Abstract

Nonmelanoma skin cancer (NMSC) is the most common malignancy in the world, with over 5.4 million new cases diagnosed in the United States annually. Basal cell carcinoma (BCC) comprises 70–75% of these cases, and up to 85% occur in the head and neck region. Basal cell carcinoma is thus the most common cancer in the world and is reaching epidemic proportions, with an ever-rising incidence. This can be observed most strikingly in Australia, which has the highest prevalence of skin cancer in the world. BCCs less commonly cause death, but if left alone can invade locally and cause significant functional loss and morbidity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Rogers HW, Weinstock MA, Feldman SR, Coldiron BM. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. population, 2012. JAMA Dermatol. 2015;151(10):1081–6.

    Article  PubMed  Google Scholar 

  2. Staples MP, Elwood M, Burton RC, et al. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust. 2006;184:6–10.

    Article  PubMed  Google Scholar 

  3. Marzuka AG, Book SE. Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management. Yale J Biol Med. 2015;88(2):167–79.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Armstrong BK, Kricker A, English DR. Sun exposure and skin cancer. Australas J Dematol. 1997;38:1): 1–6.

    Article  Google Scholar 

  5. Chuang TY, Popescu A, Su WP, Chute CG. Basal cell carcinoma. A population-based incidence study in Rochester, Minnesota. J Am Acad Dermatol. 1990;22(3):413–7.

    Article  CAS  PubMed  Google Scholar 

  6. Kricker A, Armstrong BK, English DR, Heenan PJ. Does intermittent sun exposure cause basal cell carcinoma? A case-control study in Western Australia. Int J Cancer. 1995;60(4):489–94.

    Article  CAS  PubMed  Google Scholar 

  7. Iannacone MR, Wang W, Stockwell HG, O’Rourke K, Giuliano AR, Sondak VK, Messina JL, Roetzheim RG, Cherpelis BS, Fenske NA, Rollison DE. Patterns and timing of sunlight exposure and risk of basal cell and squamous cell carcinomas of the skin—a case control study. BMC Cancer. 2012;12:417.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Ferrucci LM, Cartmel B, Molinaro AM, Leffell DJ, Bale AE, Mayne ST. Indoor tanning and risk of early-onset basal cell carcinoma. J Am Acad Dermatol. 2011;67(4):552–62.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Robinson SN, Zens MS, Perry AE, Spencer SK, Duell EJ, Karagas MR. Photosensitizing agents and the risk of non-melanoma skin cancer: a population-based case-control study. J Invest Dermatol. 2013;133(8):1950–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Karagas MR, Stukel TA, Greenberg ER, Baron JA, Mott LA, Stern RS. Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. Skin Cancer Prevention Study Group. JAMA. 1992;267(24):3305–10.

    Article  CAS  PubMed  Google Scholar 

  11. Marghoob A, Kopf AW, Bart RS, Sanfilippo L, Silverman MK, Lee P. Risk of another basal cell carcinoma developing after treatment of a basal cell carcinoma. J Am Acad Dermatol. 1998;28(1):22–8.

    Article  Google Scholar 

  12. Kanjilal S, Strom SS, Clayman GL, Weber RS, el-Naggar AK, Kapur V, Cummings KK, Hill LA, Spitz MR, Kripke ML, et al. P53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization. Cancer Res. 1995;55(16):3604–9.

    CAS  PubMed  Google Scholar 

  13. Karagas MR, McDonald JA, Greenberg ER, Stukel TA, Weiss JE, Baron JA, Stevens MM. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For the Skin Cancer Prevention Study Group. J Natl Cancer Inst. 1996;88(24):1848–53.

    Article  CAS  PubMed  Google Scholar 

  14. Boonchai W, Green A, Ng J, Dicker A, Chenevix-Trench G. Basal cell carcinoma in chronic arsenicism occurring in Queensland, Australia, after ingestion of an asthma medication. J Am Acad Dermatol. 2000;43(4):664–9.

    Article  CAS  PubMed  Google Scholar 

  15. Webb MC, Compton F, Andrews PA, Koffman CG. Skin tumors post transplantation: a retrospective analysis at a single center. Transplant Proc. 1997;29:828–30.

    Article  CAS  PubMed  Google Scholar 

  16. Hartevelt MM, Bavinck JN, Kootte AMM, Vermeer BJ, Vandenbroucke JP. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation. 1990;49:506–9.

    Article  CAS  PubMed  Google Scholar 

  17. Ramsay HM, Fryer AA, Hawley CM, Smith AG, Harden PN. Non-melanoma skin cancer risk in the Queensland renal transplant population. Br J Dermatol. 2002;147:950–6.

    Article  CAS  PubMed  Google Scholar 

  18. Jensen P, Hansen S, Moller B, Leivestad T, Pfeffer P, Geiran O, Fauchald P, Simonsen S. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol. 1999;40(2):177–86.

    Article  CAS  PubMed  Google Scholar 

  19. Ducloux D, Carron PL, Rebibou JM, Aubin F, Fournier V, Bresson-Vautrin C, Blanc D, Humbert P, Chalopin JM. CD4 lymphocytopenia as a risk factor for skin cancers in renal transplant patients. Transplantation. 1998;65(9):1270–2.

    Article  CAS  PubMed  Google Scholar 

  20. Omland SH, Ahlstrom MG, Gerstoft J, Pedersen G, Mohey R, Pedersen C, Kronborg G, Larsen CS, Kvinesdal B, Gniadecki R, Obel N, Omland LH. Risk of skin cancer in HIV-infected patients: a Danish nationwide cohort study. J Am Acad Dermatol. 2018;18:30475, epub ahead of print.

    Google Scholar 

  21. Gorlin RJ, Goltz RW. Multiple nevoid basal-cell epithelioma, jaw cysts, and bifid rib. A syndrome. N Engl J Med. 1960;262:908–12.

    Article  CAS  PubMed  Google Scholar 

  22. Farndon PA, Del Mastro RG, Evans DG, Kilpatrick MW. Location of gene for Gorlin syndrome. Lancet. 1992;339(8793):581–2.

    Article  CAS  PubMed  Google Scholar 

  23. Gailani MR, Leffell DJ, Ziegler A, Gross EG, Brash DE, Bale AE. Relationship between sunlight exposure and a key genetic alteration in basal cell carcinoma. J Natl Cancer Inst. 1996;88(6):349–54.

    Article  CAS  PubMed  Google Scholar 

  24. Stone DM, Hynes M, Armanini M, Swanson TA, Gu Q, Johnson RL, et al. The tumour-suppressor gene patched encodes a candidate receptor for Sonic Hedgehog. Nature. 1996;384(6605):129–34.

    Article  CAS  PubMed  Google Scholar 

  25. Fan H, Oro AE, Scott MP, Khavari PA. Induction of basal cell carcinoma features in transgenic human skin expressing Sonic Hedgehog. Nat Med. 1997;3(7):788–92.

    Article  CAS  PubMed  Google Scholar 

  26. De Zwaan SE, Haass NK. Genetics of basal cell carcinoma. Australas J Dermatol. 2010;51(2):81–92.

    Article  PubMed  Google Scholar 

  27. Ponten F, Berg C, Ahmadian A, et al. Molecular pathology in basal cell cancer with p53 as a genetic marker. Oncogene. 1997;15(9):1059–67.

    Article  CAS  PubMed  Google Scholar 

  28. Omland SH. Local immune response in cutaneous basal cell carcinoma. Dan Med J. 2017;64(10):5412.

    Google Scholar 

  29. Bichakjian CK, Olencki T, Aasi SZ, et al. Basal cell skin cancer, version 1.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2016;14(5):574–97.

    Article  Google Scholar 

  30. Amin MB, Edge S, Greene F, et al., editors. AJCC cancer staging manual. 8th ed. New York: Springer; 2017.

    Google Scholar 

  31. Miller SJ, Alam M, Andersen J, Berg D, Bichakjian CK, Bowen G, et al. Basal cell and squamous cell skin cancers. J Natl Compr Cancer Netw. 2010;8(8):836–64.

    Article  Google Scholar 

  32. Wolf DJ, Zitelli JA. Surgical margins for basal cell carcinoma. Arch Dermatol. 1987;123(3):340–4.

    Article  CAS  PubMed  Google Scholar 

  33. Jerant AF, Johnson JT, Sheridan CD, Caffrey TJ. Early detection and treatment of skin cancer. Am Fam Physician. 2000;62(2):357–82.

    CAS  PubMed  Google Scholar 

  34. van Loo E, Mosterd K, Krekels GA, Roozeboom MH, Ostertag JU, Dirksen CD, Steijlen PM, Neumann HA, Nelemans PJ, Kelleners-Smeets NW. Surgical excision versus Mohs micrographic surgery for basal cell carcinoma of the face: a randomized clinical trial with 10 years follow-up. Eur J Cancer. 2014;50(17):3011–20.

    Article  PubMed  Google Scholar 

  35. Muller FM, Dawe RS, Moseley H, Fleming CJ. Randomized comparison of Mohs micrographic surgery and surgical excision for small nodular basal cell carcinoma: tissue-sparing outcome. Dermatol Surg. 2009;35(9):1349–54.

    Article  CAS  PubMed  Google Scholar 

  36. Yalcin O, Sezer E, Kabukcuoglu F, Kilic AI, Sari AG, Cerman AA, Altunay IK. Presence of ulceration, but not high risk zone location, correlates with unfavorable histopathological subtype in facial basal cell carcinoma. Int J Clin Exp Pathol. 2015;8(11):15448–53.

    PubMed  PubMed Central  Google Scholar 

  37. Von Domarus H, Stevens PJ. Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol. 1984;10(6):1043–60.

    Article  Google Scholar 

  38. Ozgediz D, Smith EB, Zheng J, Otero J, Tabatabai ZL, Corvera CU. Basal cell carcinoma does metastasize. Dermatol Online J. 2008;14(8):5.

    PubMed  Google Scholar 

  39. Wadhera A, Fazio M, Bricca G, Stanton O. Metastatic basal cell carcinoma: a case report and literature review. How accurate is our incidence data? Dermatol Online J. 2006;12(5):7.

    PubMed  Google Scholar 

  40. Jankovic I, Kovacevic P, Visnjic M, et al. Application of sentinel lymph node biopsy in cutaneous basosquamous carcinoma. Ann Dermatol. 2011;23(1):123–6.

    Article  Google Scholar 

  41. McGovern S, Ballo M. Radiation oncology in skin cancer treatment. In: MacFarlane D, editor. Skin Cancer management. New York: Springer; 2010. p. 259–71.

    Google Scholar 

  42. Petrovich Z, Kuisk H, Langholz B, et al. Treatment results and patterns of failure in 646 patients with carcinoma of the eyelids, pinna, and nose. Am J Surg. 1987;154(4):447–50.

    Article  CAS  PubMed  Google Scholar 

  43. Kwan W, Wilson D, Moravan V. Radiotherapy for locally advanced basal cell and squamous cell carcinomas of the skin. Int J Radiat Oncol Biol Phys. 2004;60(2):406–11.

    Article  PubMed  Google Scholar 

  44. Jackson JE, Dickie GJ, Wiltshire KL, et al. Radiotherapy for perineural invasion in cutaneous head and neck carcinomas: toward a risk-adapted treatment approach. Head Neck. 2009;31(5):604–10.

    Article  PubMed  Google Scholar 

  45. Lott DG, Manz R, Koch C, Lorenz RR. Aggressive behavior of nonmelanotic skin cancers in solid organ transplant recipients. Transplantation. 2010;90(6):683–7.

    Article  PubMed  Google Scholar 

  46. Sekulic A, Migden MR, Oro AE, et al. Efficacy and safety of vismodegib in advanced basal cell carcinoma. N Engl J Med. 2012;366(23):2171–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Jain S, Song R, Xie J. Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas. Onco Targets Ther. 2017;10:1645–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Dummer R, Guminski A, Gutzmer R, et al. The 12-month analysis from basal cell carcinoma outcomes with LDE225 treatment (BOLT): a phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma. J Am Acad Dermatol. 2016;75(1):113–25.

    Article  CAS  PubMed  Google Scholar 

  49. Midgen MR, Guminski A, Gutzmer R, et al. Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial. Lancet Oncol. 2015;16(6):716–28.

    Article  CAS  Google Scholar 

  50. Xie P, Lefrançois P. Efficacy, safety, and comparison of sonic hedgehog inhibitors in basal cell carcinomas: a systematic review and meta-analysis. J Am Acad Dermatol. 2018;79:1089. https://doi.org/10.1016/j.jaad.2018.07.004.

    Article  CAS  PubMed  Google Scholar 

  51. Odom D, Mladsi D, Purser M, et al. A matching-adjusted indirect comparison of sonidegib and vismodegib in advanced basal cell carcinoma. J Skin Cancer. 2017;2017:ePub 6121760.

    Article  Google Scholar 

  52. Block AM, Alite F, Diaz AD. Combination trimodality therapy using vismodegib for basal cell carcinoma of the face. Case Rep Oncol Med. 2015;2015:1. https://doi.org/10.1155/2015/827608.

    Article  Google Scholar 

  53. Hehlgans S, Booms P, Gullulu O, et al. Radiation sensitization of basal cell and head and neck squamous cell carcinoma by the hedgehog pathway inhibitor vismodegib. Int J Mol Sci. 2018;19(9):E2485.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Baylor College of Medicine, Department of Otolaryngology, Houston, TX, USA

    Sagar Kansara

  2. The University of Texas MD Anderson Cancer Center, Department of Head and Neck Surgery, Houston, TX, USA

    Christopher M. K. L. Yao & Neil D. Gross

Authors
  1. Sagar Kansara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher M. K. L. Yao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Neil D. Gross
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The University of Texas MD Anderson Cancer Center, Departments of Dermatology and Head and Neck Surgery, Mohs Surgery Center, Houston, TX, USA

    Michael R. Migden

  2. The University of Texas MD Anderson Cancer Center, Department of Dermatology, Houston, TX, USA

    Leon Chen

  3. University of Texas McGovern Medical School at Houston, Department of Dermatology, Houston, TX, USA

    Sirunya Silapunt

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kansara, S., Yao, C.M.K.L., Gross, N.D. (2020). Surgical Treatment for Basal Cell Carcinoma of the Head and Neck. In: Migden, M., Chen, L., Silapunt, S. (eds) Basal Cell Carcinoma. Springer, Cham. https://doi.org/10.1007/978-3-030-26887-9_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-26887-9_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-26886-2

  • Online ISBN: 978-3-030-26887-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation